Thorne HealthTech Future Growth

Future criteria checks 4/6

Thorne HealthTech is forecast to grow earnings and revenue by 57.2% and 19.8% per annum respectively while EPS is expected to grow by 56.6% per annum.

Key information

57.2%

Earnings growth rate

56.6%

EPS growth rate

Personal Products earnings growth7.6%
Revenue growth rate19.8%
Future return on equityn/a
Analyst coverage

Low

Last updated16 Oct 2023

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:F7G - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20254186865722
12/31/20243633461683
12/31/20232881617472
6/30/202325820-1522N/A
3/31/202324010-254N/A
12/31/202222916-135N/A
9/30/20222166-14-6N/A
6/30/20222063-51N/A
3/31/20221949-11-4N/A
12/31/2021184449N/A
9/30/2021172-1812N/A
6/30/2021162-1912N/A
3/31/2021150-32023N/A
12/31/2020138-31517N/A
12/31/2019103-22-11-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: F7G's forecast earnings growth (57.2% per year) is above the savings rate (0.4%).

Earnings vs Market: F7G's earnings (57.2% per year) are forecast to grow faster than the German market (14.7% per year).

High Growth Earnings: F7G's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: F7G's revenue (19.8% per year) is forecast to grow faster than the German market (4.6% per year).

High Growth Revenue: F7G's revenue (19.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if F7G's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.